Computational methods in glaucoma research: current status and future outlook

MJ Kim, CA Martin, J Kim, MM Jablonski - Molecular Aspects of Medicine, 2023 - Elsevier
Advancements in computational techniques have transformed glaucoma research, providing
a deeper understanding of genetics, disease mechanisms, and potential therapeutic targets …

Ubiquitin proteasome system and glaucoma: A survey of genetics and molecular biology studies supporting a link with pathogenic and therapeutic relevance

I Pandino, S Giammaria, GA Zingale, G Roberti… - Molecular Aspects of …, 2023 - Elsevier
Glaucoma represents a group of progressive neurodegenerative diseases characterized by
the loss of retinal ganglion cells (RGCs) and their axons with subsequent visual field …

Evaluation of Pregabalin bioadhesive multilayered microemulsion IOP-lowering eye drops

DN Maria, MM Ibrahim, MJ Kim, SN Maria… - Journal of Controlled …, 2024 - Elsevier
In spite of available treatment options, glaucoma continues to be a leading cause of
irreversible blindness in the world. Current glaucoma medications have multiple limitations …

[HTML][HTML] Neuroretinal Cell Culture Model as a Tool for the Development of New Therapeutic Approaches for Oxidative Stress-Induced Ocular Diseases, with a Focus …

KN Fomo, N Perumal, C Manicam, N Pfeiffer, FH Grus - Cells, 2024 - mdpi.com
Glaucoma is a heterogeneous group of optic neuropathies characterized by a progressive
degeneration of the retinal ganglion cells (RGCs), leading to irreversible vision loss …

[HTML][HTML] Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear …

C Schmelter, KN Fomo, A Brueck, N Perumal… - Biomolecules, 2023 - mdpi.com
Glaucoma is a complex, multifactorial optic neuropathy mainly characterized by the
progressive loss of retinal ganglion cells (RGCs) and their axons, resulting in a decline of …